| Presentation Title |
Name |
At the end of the presentation, participants will be able to: |
| Leadless Pacemakers / Non-Transvenous ICDs |
Dr. Blandine Mondésert |
- Evaluate the latest technologies in pacing and defibrillation
- Describe the results of the latest clinical trials on new technologies in pacing and defibrillation field
- Discuss the indication and practical implications of new technologies in pacing and defibrillation
|
| Left Atrial Appendage Closure: New Technologies, New Evidence |
Dr. Jeff Healey |
- Describe the approaches to left atrial appendage closure
- Explain the effect of left atrial appendage closure on clinical endpoints
- Discuss populations who might benefit from left atrial appendage closure
|
| Left Bundle Branch Pacing: Where Are We Now? |
Dr. Jacqueline Joza |
- Describe the ECG characteristics of left bundle branch pacing (LBBP)
- Identify which patients may most benefit from LBBP
- Discuss the most up to date literature on LBBP
|
| Devices to Monitor and Treat Hearty Failure |
Dr. Anique Ducharme |
- Illustrate the importance of congestion in the development of decompensated heart failure
- Differentiate strategies currently available in Canada for remote assessment of HF patients
- Explain the clinical benefits of remote haemodynamics assessment of heart failure
|
| ECG Quizzes |
Drs. Charles Dussault,
Jeff Healey,
Jean-François Roux |
- Interpret complex electrocardiographic tracings
- Discuss rare ECG findings in clinical care
- List evidence-based assessment of electrocardiographic findings
|
| Modifiable Risk Factors in Atrial Fibrillation |
Dr. Jason Andrade |
- Discuss the implications of modifiable risk factors in the context of atrial fibrillation
- Evaluate the latest evidence regarding risk factor modification for patients with established atrial fibrillation
|
| Atrial Fibrillation and Heart Failure |
Dr. Jean-François Roux |
- Describe the clinical impact of atrial fibrillation in patients with heart failure
- Discuss the various approaches to pharmacological therapy
- Summarize the role of atrial fibrillation ablation in patients with heart failure
|
| ICD and CRT Implantation in HF: Who to Refer in 2023 |
Dr. Jaimie Manlucu |
- Describe the current guideline recommendations for ICD candidacy
- Summarize the current evidence and indications for cardiac resynchronization therapy
- Discuss the evidence for conduction system pacing in heart failure
|
| Residents’ Case Challenge |
Dr. Charles Dussault |
- Summarize enlightening clinical cases involving cardiac arrhythmia and their challenges
- Apply expert feedback received during case presentation to solve complex cases
- Discuss the management challenging clinical arrhythmia cases
|
| Early Ablation of AF vs Pharmacological Therapy |
Dr. Jason Andrade |
- Discuss the evidence surrounding rhythm control and clinical outcomes
- Evaluate the latest evidence regarding AAD therapy and catheter ablation on arrhythmia recurrence and progression
|
| Sports Cardiology: A Primer |
Dr. Paul Dorian |
- Describe the normal adaptations of the heart and circulation to exercise and sport
- Identify the health consequences of exercise and sport on cardiovascular risk and longevity
- Develop an approach for the screening and management of heart disease in athletes
|
| Arrhythmias in Adults with Congenital Heart Disease: What a Cardiologist Should Know? |
Dr. Blandine Mondésert |
- Describe the most important specific arrhythmias that the cardiologist could face to in congenital patients
- Evaluate the indications for arrhythmias treatment in congenital patients
- Discuss the specificities for management of adult congenital patients with arrhythmias
|
| Contemporary Management of the Patient with Frequent Premature Ventricular Contractions |
Dr. Charles Dussault |
- Identify the site of origin of frequently encountered PVCs
- Determine which patients should be referred for catheter ablation
- Discuss the adequate long-term follow-up for patients with frequent PVC
|
| Treatment of Heart Failure: Beyond Foundational Therapies |
Dr. Anique Ducharme |
- Illustrate the importance of residual risk in patients with Heart failure and reduced ejection fraction (HFrEF)
- Explain worsening heart failure and its impact on prognosis
- Describe the role of second line strategies for patients with HFrEF and where they fit in the current treatment
- Discuss the role of iron deficiency in disease progression and establish treatment strategies
|
| Technologies in AF and HF: Leadless, Remote Monitoring, etc. |
Panel |
- Describe recommendations for remote monitoring in patients with CIED
- Discuss challenges in the implementation of a remote monitoring program
|
| Workshop 1: Leadless Devices - Pacemakers and ICDs |
Dr. Jeff Healey |
- Discuss patient selection for leadless pacemakers
- Determine which patient would benefit from an extravascular ICD
- Highlight technical elements of leadless pacemakers and extravascular ICD implants
|
| Workshop 2: LBB Pacing |
Dr. Jean-François Roux |
- Explain current indications for LBB pacing
- Identify EP characteristics of a successful LBB pacing
- Summarize technical elements of LBB pacing
|
| Workshop #3: Implantable Loop Recorders |
Dr. Jaimie Manlucu |
- Discuss patient selection for implantable loop recorder
- Distinguish technical elements of implantable loop recorder implant
|
